Skip to Content

Coagulation factor Xa Pregnancy and Breastfeeding Warnings

Coagulation factor Xa is also known as: Andexxa

Medically reviewed by Drugs.com. Last updated on Apr 17, 2019.

Coagulation factor Xa Pregnancy Warnings

The manufacturer makes no recommendation regarding use during pregnancy.

US FDA pregnancy category: Not assigned

Risk Summary: Insufficient data exists in pregnant women to inform patients of associated risks.

Animal studies have not been reported. There are no controlled data in human pregnancy.

Safety and effectiveness during labor and delivery have not been evaluated.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Coagulation factor Xa Breastfeeding Warnings

Benefits and risks should be considered.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Andexxa (coagulation factor Xa)." Portola Pharmaceuticals, South San Francisco, CA.

References for breastfeeding information

  1. "Product Information. Andexxa (coagulation factor Xa)." Portola Pharmaceuticals, South San Francisco, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide